Product Information
PRAVASTATIN SODIUM 10 MG TAB is a generic product labeled by Biocon Pharma Inc., priced at $0.0555 per EA under NDC 70377004514. Its NADAC has been published 260 times since Oct 13, 2021.
FDA first approved this application on Apr 13, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
10 mg/1
Manufacturer
Biocon Pharma Inc.NDC
70377004514
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
PRAVASTATIN SODIUMApproval Type
Generic (ANDA)
FDA Application
ANDA209869FDA Approved
4/13/2018
TE Code
AB
On Market Since
2/1/2021
Pharmacological Classes
Price Statistics
The NADAC for PRAVASTATIN SODIUM 10 MG TAB has been published 260 times since Oct 13, 2021, and over the history we have for it it has declined 35.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0555 per EA |
|---|---|
| All-time high | $0.0876 (Nov 10, 2021) |
| All-time low | $0.0461 (Nov 20, 2024) |
| 52-week high | $0.0651 |
| 52-week low | $0.0555 |
| Median price | $0.0644 |
| Average price | $0.0642 |
| Largest weekly change | +29.5% (Aug 21, 2024) |
| Weeks tracked | 260 |
| Tracking since | Oct 13, 2021 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Biocon Pharma Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Pravastatin sodium market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
HMG-CoA Reductase Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of PRAVASTATIN SODIUM 10 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for PRAVASTATIN SODIUM 10 MG TAB, manufactured by Biocon Pharma Inc., is $0.0555 per EA (NDC 70377004514), effective Sep 30, 2026.
How has the price of PRAVASTATIN SODIUM 10 MG TAB changed over time?
Over the history we have for it, the NADAC for PRAVASTATIN SODIUM 10 MG TAB has declined 35.5%. It has been tracked across 260 weekly CMS publications since Oct 13, 2021.
What are the highest and lowest recorded NADAC prices for PRAVASTATIN SODIUM 10 MG TAB?
Since Oct 13, 2021, the NADAC for PRAVASTATIN SODIUM 10 MG TAB has ranged from a low of $0.0461 (Nov 20, 2024) to a high of $0.0876 (Nov 10, 2021), with a median of $0.0644 per EA.
Are there cheaper alternatives to PRAVASTATIN SODIUM 10 MG TAB?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as PRAVASTATIN SODIUM 10 MG TAB in a comparable dosage form, but none are currently priced below it.
Who manufactures PRAVASTATIN SODIUM 10 MG TAB?
PRAVASTATIN SODIUM 10 MG TAB (NDC 70377004514) is labeled by Biocon Pharma Inc., and CMS classifies it as a generic product.